Focusing on the Use of GLP-1s in Treating MASH & Fatty Liver Disease

Time: 10:00 am
day: Conference Day One


  • Navigating the rationale behind using GLP-1s to treat MASH and fatty liver disease
  • Understanding the limitations of GLP-1 monotherapy and GLP-1/GIP dual agonists and the therapeutic benefit of glucagon-based agents